Deal Announcements

Magellan Biosciences Captures $50 Million Financing

Wednesday, November 29, 2006 6:00:00 AM PDT | VentureDeal Staff

CHELMSFORD, MA --  Magellan Biosciences announced the closing of a $50 million round of new debt and equity financing.   Funds will be used to expand product development and strategic acquisitions.

The company develops products for clinical diagnostics, hospital-based labs and near-patient testing and serves markets worldwide.

Abingworth Management led the round, which included seven previous and new investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1